Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature Reviews. Cancer|July 14, 2006
Predicting benefit from anti-angiogenic agents in malignancyAdrian M Jubb, Adam J Oates, Scott Holden, et al.
The Lancet. Haematology|December 22, 2015
Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised studyChan Yoon Cheah, David Belada, Michelle A Fanale, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2012
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancerSandhya Girish, Manish Gupta, Bei Wang, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2009
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumorsCrystal S Denlinger, Rebecca Blanchard, Lu Xu, et al.
Pageof 1